Multiple sclerosis (MS) is a complex autoimmune disorder that affects the central nervous system, leading to a wide range of neurological symptoms. While there is no cure for MS, managing one’s dietary intake can significantly influence the disease's progression and symptom severity. Certain foods can exacerbate inflammation, increase cardiovascular risks, or worsen common symptoms, making it essential to understand which dietary choices are best avoided. This comprehensive guide explores the foods to steer clear of if you want to maintain better health and improve quality of life with MS.

Foods Contributing to Heart and Blood Vessel Health Risks

In individuals diagnosed with MS, cardiovascular health is a paramount concern. Elevated cholesterol levels and unhealthy fats can heighten the risk of heart attack and stroke, which are common complications in MS patients. Trans fats, in particular, are notorious for their detrimental effects on heart health. These fats are mainly found in processed baked goods and confectionery, formulated with hydrogenated vegetable oils or shortening. Regular consumption of trans fats promotes inflammation of blood vessels, which can worsen neuroinflammatory processes tied to MS. Therefore, it is highly recommended to limit or eliminate trans fats from your diet by avoiding baked snacks like cookies, cakes, pastries, and fried foods.

Dietary Salt and Sugar: The Double-Edged Sword

Scientific research highlights sodium as a trigger for MS relapses. Excess salt intake can increase blood pressure, strain the circulatory system, and promote inflammation across blood vessels—factors linked to disease activity. Moreover, a high-sodium diet is associated with heightened immune responses, potentially worsening MS symptoms. Similarly, consuming high amounts of sugar contributes not only to weight gain but also to systemic inflammation. Excess sugar intake can lead to fatigue, one of the most common MS symptoms, and exacerbate feelings of tiredness and weakness. Both sugar and salt are inflammatory foods; thus, moderation is vital for those managing MS. The goal is to consume these nutrients within recommended limits to prevent flare-ups and support overall health.

Refined Grains and Nutritional Deficiencies

Refined grains, such as white rice, white bread, and white pasta, have undergone processing that strips away essential nutrients, including fiber, vitamins, and minerals. These foods provide little nutritional value and can contribute to blood sugar spikes, weight gain, and inflammation. Medical advice favors replacing refined grains with whole grains—like brown rice, whole wheat bread, oats, and quinoa—which are rich in fiber and support digestive health. Fiber-rich diets assist in alleviating constipation, a common issue faced by individuals with MS, and may also have anti-inflammatory properties. Transitioning to whole grains is a strategic move to enhance overall well-being and mitigate some MS symptoms.

Complementary Therapeutics for MS Management

While nutrition plays a crucial role, it is often insufficient on its own. Modern treatments and therapies are integral to managing MS effectively. Recent advancements include the utilization of disease-modifying therapies that can reduce relapse rates and slow disease progression.

PONVORY™ (ponesimod): The Oral Treatment Innovation

Recent clinical trials led to the FDA approval of PONVORY™, an oral medication designed specifically for relapsing-remitting MS. Ponesimod works by modulating specific white blood cells, preventing them from entering the central nervous system, and thereby reducing inflammation and nerve damage. Its oral administration makes it a convenient option for many patients. Patients can access cost-saving options such as Rx coupons, making treatment more affordable. Incorporating PONVORY™ into an MS management plan can help reduce the frequency and severity of relapses, improving long-term outcomes.

Ocrevus® (ocrelizumab): Targeted Immune Cell Therapy

Another highly effective treatment approved by the FDA is Ocrevus®, an infusion therapy used for relapsing and primary progressive MS. This therapy targets a specific type of immune cell known as CD20-positive B cells that play a role in disease activity. Administered through intravenous infusion every six months, Ocrevus® requires healthcare professional supervision due to the need for premedication and post-infusion monitoring, which may extend each session to up to seven hours. This targeted approach helps reduce immune system attacks on the nervous system, offering hope for stable disease management and improved quality of life.